Takeshi Yokoyama, Katsuhiro Kusaka, Mineyuki Mizuguchi, Yuko Nabeshima, Satoru Fujiwara. Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin. Journal of medicinal chemistry. 2023
Takeshi Yokoyama, Katsuhiro Kusaka. Characterization of the molecular interactions between resveratrol derivatives and death-associated protein kinase 1. The FEBS journal. 2023. 290. 18. 4465-4479
Takeshi Yokoyama, Mineyuki Mizuguchi, Yuko Nabeshima, Yusuke Nakagawa, Takuya Okada, Naoki Toyooka, Katsuhiro Kusaka. Rafoxanide, a salicylanilide anthelmintic, interacts with human plasma protein transthyretin. The FEBS journal. 2023. 290. 21. 5158-5170
Mineyuki Mizuguchi, Takeshi Yokoyama, Takuya Okada, Yusuke Nakagawa, Kanako Fujii, Yuko Nabeshima, Naoki Toyooka. Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis. Bioorganic & medicinal chemistry. 2023. 90. 117370-117370
Mineyuki Mizuguchi, Takeshi Yokoyama, Takahito Otani, Shiori Kuribara, Yuko Nabeshima, Takayuki Obita, Masato Hirata, Keiichi Kawano. Structural and mutational analyses of decarboxylated osteocalcin provide insight into its adiponectin-inducing activity. FEBS letters. 2023. 597. 11. 1479-1488